144 related articles for article (PubMed ID: 37926574)
21. Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
Kim HW; Oh M; Oh JS; Oh SJ; Lee SJ; Chung SJ; Kim JS
PLoS One; 2017; 12(1):e0169928. PubMed ID: 28085923
[TBL] [Abstract][Full Text] [Related]
22. Differences in cerebellar perfusion between Parkinson's disease and multiple system atrophy.
Murakami N; Sako W; Haji S; Furukawa T; Otomi Y; Otsuka H; Izumi Y; Harada M; Kaji R
J Neurol Sci; 2020 Feb; 409():116627. PubMed ID: 31865188
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of dual-phase
Oh M; Lee N; Kim C; Son HJ; Sung C; Oh SJ; Lee SJ; Chung SJ; Lee CS; Kim JS
Sci Rep; 2021 Jul; 11(1):14992. PubMed ID: 34294739
[TBL] [Abstract][Full Text] [Related]
24. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping.
Juh R; Pae CU; Lee CU; Yang D; Chung Y; Suh T; Choe B
Neurosci Res; 2005 Jul; 52(3):211-9. PubMed ID: 15927722
[TBL] [Abstract][Full Text] [Related]
25. Brain 18F-FDG PET imaging in the differential diagnosis of parkinsonism.
Akdemir ÜÖ; Tokçaer AB; Karakuş A; Kapucu LÖ
Clin Nucl Med; 2014 Mar; 39(3):e220-6. PubMed ID: 24321825
[TBL] [Abstract][Full Text] [Related]
26. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
Carlos AF; Sekiya H; Koga S; Pham NTT; Ali F; Botha H; Clark HM; Coon EA; Lowe V; Ahlskog JE; Trejo-Lopez JA; Dickson DW; Whitwell JL; Josephs KA
Parkinsonism Relat Disord; 2022 Aug; 101():9-14. PubMed ID: 35752126
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Extrastriatal
Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
[No Abstract] [Full Text] [Related]
28. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
[TBL] [Abstract][Full Text] [Related]
29. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.
Ghaemi M; Hilker R; Rudolf J; Sobesky J; Heiss WD
J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):517-23. PubMed ID: 12397143
[TBL] [Abstract][Full Text] [Related]
30. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
[TBL] [Abstract][Full Text] [Related]
31. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
[TBL] [Abstract][Full Text] [Related]
32. An imaging study of parkinsonism among African-Caribbean and Indian London communities.
Hu MT; Chaudhuri KR; Jarosz J; Yaguez L; Brooks DJ
Mov Disord; 2002 Nov; 17(6):1321-8. PubMed ID: 12465076
[TBL] [Abstract][Full Text] [Related]
33. Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy.
Tomše P; Rebec E; Studen A; Perovnik M; Rus T; Ležaić L; Tang CC; Eidelberg D; Trošt M
Phys Med; 2022 Jun; 98():131-138. PubMed ID: 35537328
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography/computed tomography dual imaging using 18-fluorine flurodeoxyglucose and 11C-labeled 2-β-carbomethoxy-3-β-(4-fluorophenyl) tropane for the severity assessment of Parkinson disease.
Li X; Zhang Q; Qin Y; Li Y; Mutaerbieke N; Zhao X; Yibulayin A
Medicine (Baltimore); 2020 Apr; 99(14):e19662. PubMed ID: 32243399
[TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis of multiple system atrophy with predominant parkinsonism and Parkinson's disease using neural networks.
Tsuda M; Asano S; Kato Y; Murai K; Miyazaki M
J Neurol Sci; 2019 Jun; 401():19-26. PubMed ID: 31005759
[TBL] [Abstract][Full Text] [Related]
36. Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease.
Kübler D; Kobylecki C; McDonald KR; Anton-Rodriguez JM; Herholz K; Carter SF; Hinz R; Thompson JC; Al-Fatly B; Gerhard A
Parkinsonism Relat Disord; 2023 Feb; 107():105277. PubMed ID: 36621156
[TBL] [Abstract][Full Text] [Related]
37. Manual MRI morphometry in Parkinsonian syndromes.
Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
[TBL] [Abstract][Full Text] [Related]
38. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.
Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
J Neurol Sci; 1996 Dec; 144(1-2):77-83. PubMed ID: 8994107
[TBL] [Abstract][Full Text] [Related]
39. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
[TBL] [Abstract][Full Text] [Related]
40. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
